CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Vicryl absorbable suturedevice
Likely dose
Not stated in record
Key inclusion· 5
  • Age 18 years or older
  • Able to provide informed consent
  • Scheduled for cutaneous surgical procedure on trunk or extremities with planned primary closure
  • Predicted closure length ≥4 cm
Key exclusion· 4
  • Pregnancy
  • Unable to understand written and oral English
  • Incarceration
  • Predicted wound closure length <4 cm

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03327922
NCT03327922N/ACompleted

Interrupted Subdermal Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis: a Randomized Evaluator Blinded Split Wound Comparative Effectiveness Trial

University of California, Davis·interventional·Posted Nov 1, 2017·Updated Mar 13, 2026

In Brief

A clinical study evaluating Vicryl absorbable suture for Interrupted Subdermal Suture. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study aims to investigate whether the spacing of the interrupted deep (subdermal) sutures affects surgical wound cosmesis on the trunk and extremities. In other words, the investigator would like to determine which of the following yields a more cosmetically appealing scar: many closely approximated subdermal sutures or fewer, more widely spaced subdermal sutures. The investigator wishes to compare the effects of one versus two centimeter spacing between sutures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 1, 2017
Enrollment StartSep 20, 2017
Primary CompletionMar 2, 2022
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 8.7 years ago

Interventions

Vicryl absorbable suturedevice

Vicryl absorbable suture is a synthetic sterile surgical suture made up of a copolymer